NEXGEL, Inc. (NXGL) income statement
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3099% below fair value
$3.12−0.23 (-6.84%)
Close on Nov 20, 2026Market cap $1.52MP/E –Yield –
NEXGEL, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 33.4%
- Operating margin
- -58.6%
- Net margin
- -54.0%
- Return on equity, FY2025
- -58.7%
Financial strength
- Current ratio
- 0.46
- Debt to equity
- 0.10
- Debt to assets
- 1.7%
- Cash to current liabilities
- 2.6%
Valuation
- P/E ratio
- –
- Price to sales
- 0.12
- Price to book
- 0.37
- Dividend yield
- –
See a number that looks wrong?